NeoStem expands IP coverage of cardiovascular asset AMR-001

The hackers were behind scores of thefts of intellectual property and government documents over the past five years, according to a report by Mandiant in February that was confirmed by American officials. RELATED WASHINGTON: Three months after hackers working ...

The intellectual property and science business of Thomson Reuters, the provider of intelligent information for businesses and professionals, has announced the launch of its online offering, an enhanced solution with features and functionality for ...

The inaugural APEC meeting on intellectual property rights has recommended the establishment of an ad hoc Working Group within APEC to advance regional cooperation on the issue. More than 90 intellectual property experts from the APEC region met in ...

The rejection by India's Supreme Court on Novartis' Glivec/Gleevec (imatinib mesylate) and other recent case law raise important issues on patent strategies for solid forms. Pharmaceutical Technology Volume 37, Issue 5, pp. 54-58 12 JASON ...

The Intellectual Property Appellate Board (IPAB) has informed the Madras High Court that it is facing acute fund crunch and doesn't even have the money to pay rent for its office space.

Just because a mark happens to be a common dictionary word, that is no licence for anyone to freely grab it for adoption and abuse. This was the ruling given on Tuesday by the Intellectual Propert...

The Intellectual Property Appellate Board (IPAB) has asked the Registrar of Trade Marks to cancel the trademark 'Haldiram Bhujiawala' -- the sweets and snacks brand -- issued to a Kolkata-based firm.

Big pharma may be crying hoarse over Indias weak intellectual property environment, but over the past five years or so, they have introduced only a handful of their patented blockbusters in the country.

India’s intent to respect intellectual property may have drawn international criticism following the Supreme Court’s decision on Glivec, but facts point at a different story.After Swiss multinational pharma major Novartis recently accused India of disrespecting intellectual property, data has now shown that India has granted at least 219 patents to Novartis in the pharmaceutical field. According to the data from the Indian Patent Office, India started granting product patents only ...